In an article written to coincide with International Women’s Day 2023, Baker McKenzie’s Monica Kurnatowska looks at law firm diversity and the importance of an evidence-based approach to inclusion and diversity.
This publication features the latest Financial Regulatory developments in Italy.
Baker McKenzie’s Sanctions Blog published the alert titled Focus by US, EU, UK and other authorities on third countries and anti-circumvention of Russia sanctions on 8 March 2023. Read the article via the link here. Please also visit our Sanctions Blog for the most recent updates.
A study by the Equality and Human Rights Commission found that 77% of working mothers surveyed had potentially discriminatory or negative experiences. For many, the statutory protections designed to help mothers are not effective in re-balancing the disadvantages faced. With most mothers being of working age, we explore what employers can do to tackle these issues in order to retain mothers in the workplace.
After a long period in which the UK government has promised several employment law changes contained in an Employment Bill without bringing forward such a Bill, it has now announced it is supporting certain private members’ bills which include developments in these areas. These include expanding the right to request flexible working, a new right to request more predictable working conditions, a number of changes to family leave entitlements, and protection for those facing harassment by third parties such as customers at work.
With Decision No. 131, published on 4 January 2023, the Council of State ruled on the possibility for pharmaceutical companies to know in advance the data used by the Italian Medicines Agency for the calculation of the pharmaceutical payback.
On 3 February, the European Medicines Agency, the Heads of Medicines Agencies and the European Commission launched a public consultation on the establishment of a multi-stakeholder platform to improve clinical trials in the European Union.
On 19 January 2023, the Court of Justice of the European Union specified that Art. 2(2) of Directive 2001/83/EC, pursuant to which, in case of doubt on the classification of a product as a medicine or a medical device, the provisions on medicinal products shall apply, covers both “medicinal products by function” (i.e., substances exerting pharmacological, immunological or metabolic action) and “medicinal products by presentation” (i.e., substances presented as having properties for treating or preventing disease).
With the entry into force of Regulation (EU) 2019/1009 on fertilizer products, the regulatory framework for fertilizer products within the European Union has been updated. However, national regulations may continue to be used on an optional basis. This Regulation has extended the categories of fertilizers covered and it also provides for a number of obligations for manufacturers, importers and distributors of fertilizers, including the declaration of conformity and the CE marking. Finally, guidelines have also been established for the conformity assessment of these products.
Baker McKenzie’s Sanctions Blog published the alert titled Ukraine introduces three new sets of sanctions against persons contributing to the Russian aggression against Ukraine on 28 February 2023. Read the article via the link here. Please also visit our Sanctions Blog for the most recent updates.